Pharmacies have begun receiving network termination notices from Prime Therapeutics pursuant to provider participation criteria enhancements that stipulate a 10% cap on compounding. State and Federal laws protect pharmacies against termination on these grounds and Prime’s own provider agreement terms offer certain protections that the PBM has ignored in effectuating these terminations.
Frier Levitt has been working with pharmacies to successfully reverse these terminations. Contact us today if you have been terminated from Prime pursuant to a 10% compounding cap. Deadlines are approaching and it is important to take action as soon as possible. Alternative fee arrangements available.
Past experience is no guaranty of future results and each client’s case is different.
